Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT05853640
Other study ID # 2022-05023-01
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date July 24, 2023
Est. completion date December 1, 2030

Study information

Verified date August 2023
Source Lund University
Contact Eva Ageberg, PhD
Phone +46046-2224943
Email eva.ageberg@med.lu.se
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Longstanding hip and groin pain (LHGP) is a common and debilitating problem in young to middle aged individuals. These patients often get referred to orthopedic departments. Consensus statements on the management of these patients commonly recommend a physical therapist-led intervention as the first line intervention. However, the optimal content and delivery of this intervention is currently unknown. In this study we will compare the effectiveness of usual care (unstructured physical therapist-led intervention) to a semi-structured, progressive individualized physical therapist-led intervention on hip-related quality of life in people with longstanding hip and groin pain referred to an orthopedic department.


Description:

This study is a parallel-group randomized controlled trial, comparing the effectiveness of patient education and exercise therapy to usual care on hip-related quality of life in people with longstanding hip and groin pain referred to an orthopedic department. Participants will be allocated in a 1:1 ratio to either usual care (orthopedic diagnostic pathway and recommendation of physical therapy) or the HIPSTER model, a semi-structured, progressive and individualized physical therapist-led intervention focusing on patient education and exercise therapy. The primary aim of this trial is to determine the effectiveness of a structured physical therapist-led treatment model (HIPSTER) compared to usual care on hip-related quality of life. The primary hypothesis is that the HIPSTER model will be superior to usual care by at least 10 points between group change in improving self-reported hip-related function and quality of life, measured by iHOT-33. Secondary aims include comparing group differences in achievement of patient acceptable symptom state (PASS) at 4 months and to compare between group changes in self-reported physical activity, pain self-efficacy, and pain catastrophizing, and physical performance tests regarding ROM, muscle force production, hop performance and balance between the HIPSTER group and usual care (baseline to 4 months), as well as cost-effectiveness of the interventions. A full trial protocol will be published. The primary analysis will be performed using a t-test, according to intention-to-treat principles. A per protocol analysis will also be conducted, comparing participants who completed usual care or the HIPSTER model with high fidelity. Relevant parametric and non-parametric tests will be performed to compare change in physical performance tests and secondary PROMs. A subgroup of patients will be included in qualitative study, using a semi-structured interview to capture the experience of participating in the HIPSTER intervention. Another subgroup will perform more advanced biomechanical analysis, including 3d-motion analysis.


Recruitment information / eligibility

Status Recruiting
Enrollment 122
Est. completion date December 1, 2030
Est. primary completion date May 1, 2026
Accepts healthy volunteers No
Gender All
Age group 18 Years to 55 Years
Eligibility Inclusion Criteria: - Men and women aged 18-55 years - Referred to the Dept of Orthopedics due to hip and/or groin pain - Activity-related unilateral or bilateral groin pain >3 months - Pain reproduced with the FADIR test. Exclusion Criteria: - Groin pain originating from any diagnosis with other treatment pathways, i.e., i) Acute traumatic hip injuries (such as hip dislocation, hip fractures); ii) Verified moderate or severe OA (Tönnis grade >1); iii) Palpable hernia; iv) Low-back pain with a positive straight leg raise test and/or hip and groin pain provoked primarily by repeated motions of the lumbar spine; v) Sacroiliac joint pain with thigh thrust test. - Co-morbidities potentially interfering with treatment, i.e., i) Co-morbidities overriding the hip and groin-related symptoms and dysfunction (such as other acute lower limb injuries, rheumatoid arthritis etc), ii) Co-morbidities prohibiting physical activity and training (heart disease etc), iii) Current psycho-social disorders requiring treatment. - Other: i) History of drug abuse within the last year; ii) Not understanding the language of interest (Scandinavian languages, or English).

Study Design


Intervention

Other:
Usual care
Usual care at the orthopedic department consists of a clinical examination, radiological imaging, and a diagnostic injection. A recommendation to get physical therapy treatment in primary care will be provided, but this intervention will not be controlled by the investigators in any capacity.
HIPSTER
Patients will be provided with usual care at the orthopedic department, which consists of a clinical examination, radiological imaging, and a diagnostic injection. In addition, participants in this group will be referred to physical therapists trained in administering a semi-structured, individualized, progressive treatment. This 16-week intervention targets known physical and psychological impairments in people with long-standing hip and groin pain, using exercise therapy and patient education.

Locations

Country Name City State
Sweden Skane University Hospital Malmö

Sponsors (1)

Lead Sponsor Collaborator
Lund University

Country where clinical trial is conducted

Sweden, 

Outcome

Type Measure Description Time frame Safety issue
Other Qualitative interviews - Patients A sub-group of participants (about 10 or until saturation) will be interviewed in a semi-standardised fashion, about their experiences of undergoing the intervention. The interviews will be conducted between 4 months and 6 months after baseline.
Other Qualitative interviews - Physical therapists Physical therapists trained in delivering the intervention in the experimental arm will be interviewed in a semi-standardised fashion, about their experiences of treating this patient population and their experience of delivering the experimental intervention. The interviews will be conducted during active data collection, when clinicians have treated a minimum of 3 patients in the trial, with an estimated average of 6 months after data collection has started.
Primary Change in iHOT-33 scores at 4 months iHOT-33 is a 33 question self-reported outcome scale, measuring hip-related quality of life. This outcome measure has been validated and translated to Swedish. The scores are summed on a 0 (worst)-100 (best) scale. The primary outcome will be collected at baseline and at the primary end-point (4 months after baseline).
Secondary Change in iHOT-33 scores at 1, 2 and 5 years iHOT-33 is a 33 question self-reported outcome scale, measuring hip-related quality of life. This outcome measure has been validated and translated to Swedish. The scores are summed on a 0 (worst)-100 (best) scale. This outcome will be collected at baseline and 1,2 and 5 years after baseline.
Secondary Patient acceptable symptom state (PASS) The patient acceptable symptom state (PASS) will be collected using a dichotomized question ("Taking into account your hip and groin function and pain, and how it affects your daily life, including your ability to participate in sport and social activities, do you consider that your current state is acceptable if it remained like that for the rest of your life?"). This outcome will be collected at the primary endpoint (4 months after baseline). In addition it will also be collected at 1,2 and 5 years after baseline.
Secondary Treatment failure Treatment failure will be collected using a dichotomized question "Do you consider your current state so unsatisfactory that you think your treatment has failed?". This outcome will be collected at the primary endpoint (4 months after baseline). In addition it will also be collected at 1,2 and 5 years after baseline.
Secondary Perceived symptom improvement Perceived symptom improvement will be collected using a 7-point Global rating of change (GROC) scale, ranging from -3 (a lot worse), to +3 (a lot better). This outcome will be collected at the primary endpoint (4 months after baseline). In addition it will also be collected at 1 year after baseline.
Secondary Patient desire and beliefs regarding surgical intervention Patient desire and beliefs regarding surgical intervention will be collected using two dichotomized questions; "Do you want to undergo surgery?" and "Do you believe surgery is needed for you to get better?". This outcome will be collected at baseline and at the primary endpoint (4 months after baseline). In addition it will also be collected at 1 year after baseline.
Secondary Physical activity Physical activity and return to sport/exercise will be collected using questions based on the Swedish National Board of Health and Welfare (Socialstyrelsen) physical activity screening, a self-reported measure of minutes spent doing strenuous and everyday activities. This outcome will be collected at baseline and at the primary endpoint (4 months after baseline). In addition it will also be collected at 1 year after baseline.
Secondary Pain catastrophizing Pain catastrophizing will be measured with the Pain Catastrophizing Scale (PCS), a valid patient-reported outcome with 13 items. It is scored 0 to 52, with higher values indicating higher degrees of catastrophizing. This outcome will be collected at baseline and at the primary endpoint (4 months after baseline). In addition it will also be collected at 1 year after baseline.
Secondary Pain self-efficacy Pain-related self-efficacy will be collected with the short-form Pain Self-efficacy Questionnaire (PSEQ-2), a commonly used measure of self-efficacy in musculoskeletal pain. PSEQ-2 consists of 2 questions. It is scored 0 to 12, with higher score indicating a greater degree of pain self-efficacy. This outcome will be collected at baseline and at the primary endpoint (4 months after baseline). In addition it will also be collected at 1 year after baseline.
Secondary Health related quality of life Generic health-related quality of life will be measured using EQ5D. It is scored from 0 to 1, where 1 corresponds to perfect health, and is available in Swedish. This outcome will be collected at baseline and at the primary endpoint (4 months after baseline). In addition it will also be collected at 1 year after baseline.
Secondary Employment status Employment status will be measured using a Likert scale, from unemployed, student, part time work, full time work or retired. This outcome will be collected at baseline and at the primary endpoint (4 months after baseline). In addition it will also be collected at 1 year after baseline.
Secondary Surgical interventions Any performed surgical interventions to the hip and/or groin region will be collected from medical records and self-reported questions. This outcome will be collected from medical records at 1, 2 and 5 years.
Secondary Osteoarthritis development The presence of narrowing joint space will be measured using Tönnis grade, measured on an AP radiograph. This measure will be collected at baseline, and at 2 and 5 year follow ups.
Secondary Usual care content Any physical therapist-led intervention in the usual care group will be collected using self-reported questions regarding volume (number of sessions), content (overall focus of intervention) and adherence (patient compliance to prescribed intervention). This outcome will be collected from the usual care group, after the primary end-point at 4 months.
Secondary Hip range of motion Hip range of motion (in degrees) will be measured with a digital inclinometer in internal rotation in 90° of hip flexion and zero° flexion. This outcome will be collected at baseline and at the primary endpoint (4 months after baseline). In addition it will also be collected at 1 year after baseline.
Secondary Isometric hip muscle force production Isometric hip muscle force production will be measured (in Newton and nm/kg) with a belt-fixated handheld dynamometer for hip adduction, flexion and hip extension. This outcome will be collected at baseline and at the primary endpoint (4 months after baseline). In addition it will also be collected at 1 year after baseline.
Secondary Hop performance Hop performance will be assessed using the single leg hop for distance test. Distance (cm) and kinematics (joint angles) and forces (joint moments) will be measured. This outcome will be collected at baseline and at the primary endpoint (4 months after baseline). In addition it will also be collected at 1 year after baseline.
Secondary Y-balance test Single leg balance will be assessed using the Y-balance test. Distance (cm) and Limb symmetry index will be collected. This outcome will be collected at baseline and at the primary endpoint (4 months after baseline). In addition it will also be collected at 1 year after baseline.
Secondary Single leg balance Single leg balance will be evaluated by postural sway using markers, 3D-motion capture and force plates. This outcome will be collected at baseline and at the primary endpoint (4 months after baseline). In addition it will also be collected at 1 year after baseline.
Secondary Single leg squat Single leg squat performance will be evaluated using markers, 3D-motion capture and force plates to calculate kinematics (joint angles) and kinetics (joint moments) related to the task. This outcome will be collected at baseline and at the primary endpoint (4 months after baseline). In addition it will also be collected at 1 year after baseline.
Secondary Step down Step down performance will be evaluated using markers, 3D-motion capture and force plates to calculate kinematics (joint angles) and kinetics (joint moments) related to the task. This outcome will be collected at baseline and at the primary endpoint (4 months after baseline). In addition it will also be collected at 1 year after baseline.
Secondary Rear foot elevated split squat jump Lower body power will be evaluated using markers, 3D-motion capture and force plats to collect kinematics (joint angles) and kinetics (joint moments) during the task. This outcome will be collected at baseline and at the primary endpoint (4 months after baseline). In addition it will also be collected at 1 year after baseline.
See also
  Status Clinical Trial Phase
Completed NCT03590145 - Reliability of the Doha Agreement Classification of Groin Pain
Completed NCT06083428 - Erector Spinae vs. PENG Block for Total Hip Arthroplasty Phase 4
Completed NCT05551000 - Functional Training to Improve Everyday Performance in Elderlies N/A
Completed NCT04289922 - Validation of the Norwegian VISA-G Questionnaire
Recruiting NCT05868369 - The Effectiveness of Immersive Virtual Reality as a Pain Control Modality After Hip Arthroscopy N/A
Completed NCT04211987 - Fast Track Total Hip Arthroplasty vs Standard Care N/A
Recruiting NCT04736641 - Cross-cultural Adaptation, Reliability and Validity of the Turkish Version of the Japanese Orthopaedic Association Hip Disease Evaluation Questionnaire
Completed NCT02947178 - Hip Arthroscopy Pain Control Randomized Control Trial (RCT) Phase 4
Recruiting NCT03985280 - Radiofrequency Versus Intraarticular Local Anesthestic and Steroids Injection for Chronic Hip Pain. Phase 4
Completed NCT05944380 - PENG Block for Total Hip Arthroplasty Phase 4
Completed NCT05261009 - PENG Block Versus LP Block for THA Postop Pain Phase 4
Recruiting NCT05022381 - Treatment of Chronic Hip Pain by Application of Conventional Radiofrequency Thermocoagulation to the Articular Branches of the Femoral and Obturatory Nerve N/A
Completed NCT03248934 - Patient Performed Examination for Patients With Intra-articular Hip Pain N/A
Completed NCT03720821 - Cognitive Flexibility Training for Persistent Pain: Neuroimaging Pilot (COFLEX-i) N/A
Completed NCT04393909 - Improving Safety of Diagnosis and Therapy in the Inpatient Setting N/A
Recruiting NCT04027140 - MDR - M/L Taper With Kinectiv Technology Stems and Necks
Recruiting NCT03490071 - Long-term Follow up of Patients With Longstanding Hip and Groin Pain
Recruiting NCT04028687 - MDR - PMCF Study for Taperloc Complete Stems
Recruiting NCT03576625 - Effect of Buglossoides Oil on Recent Chronic Non-injurious Hip and Knee Pain Phase 1
Recruiting NCT06221709 - Continuous Radiofrequency in Hip Osteoarthritis Pain: A Randomized Clinical Trial. N/A